Allspring Global Investments
HZNP

Allspring Global Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Allspring Global Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,548
Closed -$1.45M – 2853
2023
Q3 		$1.45M Sell
12,548
-66,827
-84% -$7.18M ﹤0.01% 1275
2023
Q2 		$8.16M Sell
79,375
-112,139
-59% -$11.8M 0.01% 849
2023
Q1 		$20.9M Sell
191,514
-219,067
-53% -$24.2M 0.03% 579
2022
Q4 		$46.7M Sell
410,581
-779,480
-65% -$64.7M 0.08% 338
2022
Q3 		$73.7M Sell
1,190,061
-488,659
-29% -$34.1M 0.13% 204
2022
Q2 		$134M Buy
1,678,720
+283,962
+20% +$26.9M 0.22% 111
2022
Q1 		$147M Buy
1,394,758
+9,535
+0.7% +$929K 0.19% 135
2021
Q4 		$149M Buy
+1,385,223
New +$151M 0.17% 163

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Allspring Global Investments's HZNP Position: Q4 2023 in Review

Allspring Global Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 12,548 shares — an estimated $1.45M sold.

Allspring Global Investments first reported a position in HZNP in Q4 2021 and held it in 8 quarters. The position peaked at $149M in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Allspring Global Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 12,548 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.45M.
  • Allspring Global Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $149M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.